Although some studies identify age as a risk factor, Bieber et al., for baricitinib in AD, did not observe a clear trend of increasing HZ incidence with age [ 8 ].
← all excerpts
Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors.
1
—
—